• Moving beyond checkbox compliance toward intelligent, scalable validation frameworks that reduce risk and accelerate timelines
• How automation and risk-based methodologies are transforming validation from a bottleneck into a competitive advantage
• Practical strategies for building validation infrastructure that scales across modalities, sites, and regulatory jurisdictions
• Real-world lessons from scaling complex biologics programs and what they mean for the broader industry